论文部分内容阅读
采用伊曲康唑间歇冲击疗法治疗甲真菌病 35例，每月连续服药 1周，每天 400 mg，午饭及晚饭后立即服 200 mg。指甲真菌病患者采用 2周期疗法，服药 1周，休息 3周，第 5周再服药 1周，休息 3周；指趾甲真菌病或趾甲真菌病患者采用 3周期疗法，在两周期疗法的基础上再服药 1周，即第 9周再服药 1周。结果：停药后 6月临床痊愈率 77.1％，真菌学痊愈率 88.6％，停药后 9月临床痊愈 82.9％，真菌学痊愈率 94.3％。复发率 2.8％。无明显不良反应。伊曲康唑间歇冲击治疗甲真菌病疗程短，服药方便，疗效高，副反应小，复发率低，病人耐受好，值得推广。
Thirty-five cases of onychomycosis were treated with intermittent impact therapy with itraconazole for one week each month for 400 mg daily and 200 mg immediately after lunch and dinner. Nail mycosis patients using 2 cycles of therapy, taking 1 week, rest for 3 weeks, the first 5 weeks and then taking 1 week, rest for 3 weeks; refers to myeloma or toenail mycosis patients with 3 cycles of therapy, based on the two-cycle therapy Then take a week, that is, the first 9 weeks and then take medicine for 1 week. Results: The clinical cure rate was 77.1% in June after drug withdrawal, the cure rate in mycology was 88.6%, clinical recovery was 82.9% in September after discontinuation, and mycological cure rate was 94.3%. The recurrence rate was 2.8%. No obvious adverse reactions. Itraconazole intermittent impact treatment of onychomycosis short course, convenient medication, high efficacy, low side effects, low recurrence rate, patient tolerance is good, it is worth promoting.